Robert Rauker, CEO & Anthony Dyer, CFO of Belluscura #BELL reflects on their positive operational progress since their IPO

Robert Rauker, CEO & Anthony Dyer, CFO of Belluscura #BELL reflect on their positive operational progress since their IPO and discuss forthcoming plans.

Belluscura are focused on developing and commercialising innovative oxygen enrichment technologies that span broad industries and therapies.

Belluscura’s products are designed to create improved health and economic outcomes for patients, healthcare providers and insurance organisations.